PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 112 filers reported holding PMV PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $93,960 | -27.2% | 10,800 | -0.6% | 0.00% | – |
| Q3 2022 | $129,000 | -17.8% | 10,862 | -0.8% | 0.00% | – |
| Q2 2022 | $157,000 | -32.0% | 10,950 | -1.4% | 0.00% | – |
| Q1 2022 | $231,000 | -7.2% | 11,102 | +2.6% | 0.00% | – |
| Q4 2021 | $249,000 | -95.2% | 10,817 | -93.7% | 0.00% | -100.0% |
| Q3 2021 | $5,147,000 | -30.7% | 172,726 | -20.5% | 0.00% | -50.0% |
| Q2 2021 | $7,422,000 | -6.3% | 217,264 | -9.8% | 0.00% | 0.0% |
| Q1 2021 | $7,923,000 | -58.0% | 240,919 | -21.4% | 0.00% | -60.0% |
| Q4 2020 | $18,854,000 | +32.8% | 306,509 | -23.4% | 0.01% | 0.0% |
| Q3 2020 | $14,200,000 | – | 400,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |